Tuesday, February 3, 2015

Mangosteen- Cancer Superfood

This, by far, is my favorite of all the natural cancer killing foods.

Why are there so few people that have heard of this wonderful little miracle fruit?  You have NO idea what you are missing out on!  The Mangosteen fruit, and it's wonderful little skin called the pericarp, had it's beginnings from the far east.  And over the past 20+ years, they have made a major impact on the health community.

Rich in Vitamin C, Mangosteen is a strong anti-oxidant.  Many studies have shown this fruit's anti-cancer affect on breast, prostate, bladder, pacreatic, colon, melanoma, and colorectal cancers.  There are more than 50 xanthones found in the pericarp of this fruit, with many found to be beneficial in fighting cancer, reducing tumor growth and preventing metastasis. Mangosteen also works as an anti-inflammatory, and it's effect on insulin production has been found to be therapeutic to those with diabetes or obesity.  Controlling glucose levels plays a key role in weight management and cancer prevention.

Without completely taking my word, take a look at the references below or do a google search of "a-mangostin pubmed or garcinia mangostana" and see all the clinical studies done on this wonderful and miraculous fruit.

The following article was found at NaturalHealth365



Mangosteen and Cancer News” hspace=

(NaturalHealth365) Mangosteen, a tropical fruit indigenous to southeast Asia, is gaining in popularity as a dietary supplement and nutriceutical. Scientifically known as Garcinia mangostana, mangosteen features a dark purple rind and an inner pulp that is sweet, tart, juicy and refreshing.

Although Western medicine has been slow to embrace the therapeutic properties of mangosteen, it is no secret to natural healers in the far east. Since the days of the Ming dynasty, practitioners of Chinese Traditional Medicine have relied on mangosteen and its extracts to treat skin infections, wounds, dysentery and cholera.

Can mangosteen prevent heart disease and cancer?


In addition to beneficial anthocyanins, tannins, phenols and antioxidant vitamin C, mangosteen also contains plant chemicals called xanthones, incuding alpha-mangostin, beta-mangostin and gamma-mangostin. Although the names of these substances may sound as if they’re straight out of science fiction, there’s nothing fictional about their benefits.

According to Dr. Ray Sahelian, M.D, a medical doctor and specialist in herbal medicine, these xanthones can benefit conditions such as atherosclerosis, ischemic heart disease and high blood pressure. They reduce the “stickiness” of platelets, possess vasorelaxant abilities, and help prevent the cell membrane damage, inflammation and fat oxidation that can contribute to coronary disease.
In addition, evidence supporting the xanthones’ ability to prevent and even slow the growth of cancer has emerged from in vitro – or test tube – studies.

How does mangosteen inhibit cancer cell growth?

In a laboratory study, published in 2002 in Planta Medica, researchers found that yet another of mangosteen’s xanthones, known as garcinone E, had inhibitory effects on liver, stomach and lung cancer cells. This effect was confirmed in a test tube study published in 2008 in Journal of Natural Products.

Researchers screened twelve different xanthones from mangosteen and determined that three of them – garcinone E, alpha-mangostin and gamma-mangostin – inhibited the activity of breast cancer cells. The team noted that mangosteen should be further investigated for its potential to prevent breast cancer.

The studies indicating mangosteen’s therapeutic properties – performed by professional medical researchers and published in peer-reviewed journals – just kept coming. A study, published in 2004 in Journal of Ethnopharmacology, supported the ability of mangosteen extract to cause apoptosis – cell suicide – in breast cancer cells. Researchers concluded that mangosteen extracts “have potential for cancer prevention;” they also noted its “potent” antioxidant effects.

A 2009 study published in Journal of Agriculture and Food Chemistry showed that alpha-mangostin suppressed metastasis in the human prostate carcinoma cell line PC-3.

The most sweeping endorsement of mangosteen’s cancer-fighting powers came in a scientific review published in Current Molecular Medicine in 2011.

The authors assert that xanthones found in mangosteen demonstrate chemotherapeutic effects in the initiation, promotion and progression of cancer, and can control cancer cell division, growth and metastasis. They concluded that compelling evidence exists for the use of mangosteen not only to prevent cancer, but to treat it.

How, exactly, do xanthones attack cancer cells?


Xanthones inhibit molecular substances in tumor cells, including kinases and DNA polymerases. They perform cell cycle arrest, inhibit tumor cell proliferation, causes apoptosis – or self-destruction of cancer cells – and suppress the adhesion, invasion and metastasis of aggressive cancer cells.

Alpha-mangostin “preferentially targets” leukemia cells, without damaging nearby lymphocytes in the blood. Some experts believe that inflammation contributes to the development of cancer; mangosteen attacks inflammation as well by inhibiting the conversion of arachadonic acid to prostaglandin. Finally, additional cancer-fighting properties may come from mangosteen’s levels of epicatechin, the same beneficial flavonoid found in life-prolonging green tea.
- See more at: http://www.naturalhealth365.com/food_news/0895_mangosteen_cancer.html#sthash.dbuKaNDp.dpu





References:


T. Shan, Q. Ma, K. Guo, J. Liu, W. Li, F. Wang, E. Wu
Curr Mol Med. 
Published in final edited form as: Curr Mol Med. 2011 December 1; 11(8): 666–677.

2.
Zhongbo Liu, Mitchell Antalek, Linda Nguyen, Xuesen Li, Xuejiao Tian, Amy Le, Xiaolin Zi
Nutr Cancer. 
Published in final edited form as: Nutr Cancer. 2013; 65(0 1): 68–77. doi: 10.1080/01635581.2013.785011

3.
Weeranuch Seesom, Amornmart Jaratrungtawee, Sunit Suksamrarn, Chantana Mekseepralard, Piniti Ratananukul, Wasana Sukhumsirichart
BMC Complement Altern Med. 2013; 13: 182. Published online 2013 July 19. doi: 10.1186/1472-6882-13-182

4.
Fabiola Gutierrez-Orozco, Mark L. Failla
Nutrients. 2013 August; 5(8): 3163–3183. Published online 2013 August 13. doi: 10.3390/nu5083163

5.
Masa-Aki Shibata, Munekazu Iinuma, Junji Morimoto, Hitomi Kurose, Kanako Akamatsu, Yasushi Okuno, Yukihiro Akao, Yoshinori Otsuki
BMC Med. 2011; 9: 69. Published online 2011 June 3. doi: 10.1186/1741-7015-9-69

6.
Porntip Pan-In, Supason Wanichwecharungruang, Justin Hanes, Anthony J Kim
Int J Nanomedicine. 2014; 9: 3677–3686. Published online 2014 August 6. doi: 10.2147/IJN.S66511

7.
Young-Won Chin, A. Douglas Kinghorn
Mini Rev Org Chem. 
Published in final edited form as: Mini Rev Org Chem. 2008 November 1; 5(4): 355–364.doi: 10.2174/157019308786242223

8.
Juren Cen, Mingshu Shi, Yanfang Yang, Yanxia Fu, Hailing Zhou, Mengqi Wang, Zhenyi Su, Qun Wei
PLoS One. 2013; 8(6): e66503. Published online 2013 June 13. doi: 10.1371/journal.pone.0066503

9.
Xiaofang Quan, Yi Wang, Xiaofeng Ma, Yan Liang, Weixi Tian, Qingyun Ma, Hezhong Jiang, Youxing Zhao
PLoS One. 2012; 7(3): e33376. Published online 2012 March 9. doi: 10.1371/journal.pone.0033376

10.
Yukihiro Akao, Yoshihito Nakagawa, Munekazu Iinuma, Yoshinori Nozawa
Int J Mol Sci. 2008 March; 9(3): 355–370. Published online 2008 March 14.

11.
Hitomi Kurose, Masa-Aki Shibata, Munekazu Iinuma, Yoshinori Otsuki
J Biomed Biotechnol. 2012; 2012: 672428. Published online 2012 April 8. doi: 10.1155/2012/672428

12.
Tao Shan, Xi-juan Cui, Wei Li, Wan-run Lin, Hong-wei Lu, Yi-ming Li, Xi Chen, Tao Wu
Acta Pharmacol Sin. 2014 August; 35(8): 1065–1073. Published online 2014 June 30. doi: 10.1038/aps.2014.43

13.
Gongbo Li, Sakina M. Petiwala, Dana R. Pierce, Larisa Nonn, Jeremy J. Johnson
PLoS One. 2013; 8(12): e81572. Published online 2013 December 18. doi: 10.1371/journal.pone.0081572

14.
Ramida Watanapokasin, Faongchat Jarinthanan, Yukio Nakamura, Nitisak Sawasjirakij, Amornmart Jaratrungtawee, Sunit Suksamrarn
World J Gastroenterol. 2011 April 28; 17(16): 2086–2095. Published online 2011 April 28.doi: 10.3748/wjg.v17.i16.2086

15.
Titin Andri Wihastuti, Djanggan Sargowo, Askandar Tjokroprawiro, Nur Permatasari, Mohammad Aris Widodo, Setyowati Soeharto
Vasc Health Risk Manag. 2014; 10: 523–531. Published online 2014 August 21. doi: 10.2147/VHRM.S61736

16.
Jeremy J. Johnson, Sakina M. Petiwala, Deeba N. Syed, John T. Rasmussen, Vaqar M. Adhami, Imtiaz A. Siddiqui, Amanda M. Kohl, Hasan Mukhtar
Carcinogenesis. 2012 February; 33(2): 413–419. Published online 2011 December 9. doi: 10.1093/carcin/bgr291

17.
Jing J. Wang, Wei Zhang, Barbara J. S. Sanderson
Biomed Res Int. 2013; 2013: 715603. Published online 2013 September 23. doi: 10.1155/2013/715603

18.
Jintana Sattayasai, Pongsatorn Chaonapan, Tarinee Arkaravichie, Rungtip Soi-ampornkul, Sarawut Junnu, Patcharakajee Charoensilp, Jutima Samer, Jiraporn Jantaravinid, Patarabutr Masaratana, Bhoom Suktitipat, Juthatip Manissorn, Visith Thongboonkerd, Neelobol Neungton, Primchanien Moongkarndi
PLoS One. 2013; 8(12): e85053. Published online 2013 December 27. doi: 10.1371/journal.pone.0085053

19.
Fabiola Gutierrez-Orozco, Chureeporn Chitchumroonchokchai, Gregory B. Lesinski, Sunit Suksamrarn, Mark L. Failla
J Agric Food Chem. 
Published in final edited form as: J Agric Food Chem. 2013 April 24; 61(16): 3891–3900. Published online 2013 April 11. doi: 10.1021/jf4004434

20.
Oraphin Chantarasriwong, Dr. Ayse Batova, Dr. Warinthorn Chavasiri, Dr. Emmanuel A. Theodorakis
Chemistry. 
Published in final edited form as: Chemistry. 2010 September 3; 16(33): 9944–9962. doi: 10.1002/chem.201000741

21.
Kerstin P. Kainz, Liselotte Krenn, Zeynep Erdem, Hanspeter Kaehlig, Martin Zehl, Wilfried Bursch, Walter Berger, Brigitte Marian
PLoS One. 2013; 8(6): e65745. Published online 2013 June 11. doi: 10.1371/journal.pone.0065745

22.
Rathapon Asasutjarit, Papassara Larpmahawong, Asira Fuongfuchat, Vipaporn Sareedenchai, Sukitaya Veeranondha
AAPS PharmSciTech. 2014 April; 15(2): 306–316. Published online 2013 December 11.doi: 10.1208/s12249-013-0057-8

23.
Chureeporn Chitchumroonchokchai, Jennifer M. Thomas-Ahner, Jie Li, Kenneth M. Riedl, Jannarin Nontakham, Sunit Suksumrarn, Steven K. Clinton, A. Douglas Kinghorn, Mark L. Failla
Mol Nutr Food Res. 
Published in final edited form as: Mol Nutr Food Res. 2013 February; 57(2): 10.1002/mnfr.201200539. Published online 2012 December 13. doi: 10.1002/mnfr.201200539

24.
Tonali Blanco-Ayala, Rafael Lugo-Huitrón, Elizabeth M Serrano-López, Ricardo Reyes-Chilpa, Edgar Rangel-López, Benjamín Pineda, Omar Noel Medina-Campos, Laura Sánchez-Chapul, Enrique Pinzón, Trejo-Solis Cristina, Daniela Silva-Adaya, José Pedraza-Chaverrí, Camilo Ríos, Verónica Pérez de la Cruz, Mónica Torres-Ramos
BMC Complement Altern Med. 2013; 13: 262. Published online 2013 October 11. doi: 10.1186/1472-6882-13-262

25.
RYAN T. LARSON, JEFFREY M. LORCH, JULIA W. PRIDGEON, JAMES J. BECNEL, GARY G. CLARK, QUE LAN
J Med Entomol. 
Published in final edited form as: J Med Entomol. 2010 March; 47(2): 249–257.

26.
D F Finn, J J Walsh
Br J Pharmacol. 2013 September; 170(1): 23–37. Published online 2013 August 15. doi: 10.1111/bph.12138

27.
Elizabeth A. Mazzio, Karam F. A. Soliman
Phytother Res. 
Published in final edited form as: Phytother Res. 2009 March; 23(3): 385–398. doi: 10.1002/ptr.2636

29.
Rochelle R. Arvizo, Sanjib Bhattacharyya, Rachel Kudgus, Karuna Giri, Resham Bhattacharya, Priyabrata Mukherjee
Chem Soc Rev. 
Published in final edited form as: Chem Soc Rev. 2012 April 7; 41(7): 2943–2970. Published online 2012 March 5.doi: 10.1039/c2cs15355f

30.
J. Tangpong, S. Miriyala, T. Noel, C. Sinthupibulyakit, P. Jungsuwadee, D. K. St. Clair
Neuroscience. 
Published in final edited form as: Neuroscience. 2011 February 23; 175: 292–299. Published online 2010 November 11. doi: 10.1016/j.neuroscience.2010.11.007

31.
Abdalrahim F A Aisha, Khalid M Abu-Salah, Zhari Ismail, Amin Malik Shah Abdul Majid
BMC Complement Altern Med. 2012; 12: 104. Published online 2012 July 20. doi: 10.1186/1472-6882-12-104

32.
Gongbo Li, Stacey Thomas, Jeremy J. Johnson
Front Pharmacol. 2013; 4: 80. Published online 2013 June 26. doi: 10.3389/fphar.2013.00080

33.
Ping Li, Weixi Tian, Xiaofeng Ma
Mol Cancer. 2014; 13: 138. Published online 2014 June 3. doi: 10.1186/1476-4598-13-138

34.
35.
Sung-Jin Kim, Eun-Hye Hong, Bo-Ra Lee, Moon-Ho Park, Ji-Won Kim, A-Rim Pyun, Yeon-Jeong Kim, Sun-Young Chang, Young-Won Chin, Hyun-Jeong Ko
Immune Netw. 2012 December; 12(6): 253–260. Published online 2012 December 31. doi: 10.4110/in.2012.12.6.253

36.
Hei-Jen Huang, Wei-Lin Chen, Rong-Hong Hsieh, Hsiu Mei Hsieh-Li
Evid Based Complement Alternat Med. 2014; 2014: 813672. Published online 2014 December 1.doi: 10.1155/2014/813672

37.
Mohamed Yousif Ibrahim, Najihah Mohd Hashim, Syam Mohan, Mahmood Ameen Abdulla, Siddig Ibrahim Abdelwahab, Behnam Kamalidehghan, Mostafa Ghaderian, Firouzeh Dehghan, Landa Zeenelabdin Ali, Hamed Karimian, Maizatulakmal Yahayu, Gwendoline Cheng Lian Ee, Abdoreza Soleimani Farjam, Hapipah Mohd Ali
Drug Des Devel Ther. 2014; 8: 2193–2211. Published online 2014 November 6. doi: 10.2147/DDDT.S66574

38.
Mohamed Yousif Ibrahim, Najihah Mohd Hashim, Syam Mohan, Mahmood Ameen Abdulla, Behnam Kamalidehghan, Mostafa Ghaderian, Firouzeh Dehghan, Landa Zeenelabdin Ali, Ismail Adam Arbab, Maizatulakmal Yahayu, Gwendoline Ee Cheng Lian, Fatemeh Ahmadipour, Hapipah Mohd Ali
Drug Des Devel Ther. 2014; 8: 1629–1647. Published online 2014 September 27. doi: 10.2147/DDDT.S66105

39.
Xinxian Zhu, Jianjun Wang, Yang Ou, Weiwei Han, Huaifang Li
Eur J Med Res. 2013; 18(1): 46. Published online 2013 November 19. doi: 10.1186/2047-783X-18-46

40.
Guang-hui Wang, Fu-quan Jiang, Ying-hui Duan, Zhi-ping Zeng, Fan Chen, Yi Dai, Jie-bo Chen, Jinxing Liu, Jie Liu, Hu Zhou, Hai-feng Chen, Jin-zhang Zeng, Ying Su, Xin-sheng Yao, Xiao-kun Zhang
Cancer Res. 
Published in final edited form as: Cancer Res. 2013 January 1; 73(1): 307–318. Published online 2012 November 14.doi: 10.1158/0008-5472.CAN-12-2038

41.
Qinhong Xu, Jiguang Ma, Jianjun Lei, Wanxing Duan, Liang Sheng, Xin Chen, Ang Hu, Zheng Wang, Zheng Wu, Erxi Wu, Qingyong Ma, Xuqi Li
Biomed Res Int. 2014; 2014: 546353. Published online 2014 April 10. doi: 10.1155/2014/546353

42.
Wipob Suttana, Samlee Mankhetkorn, Wilart Poompimon, Ajay Palagani, Sergey Zhokhov, Sarah Gerlo, Guy Haegeman, Wim Vanden Berghe
Mol Cancer. 2010; 9: 99. Published online 2010 May 3. doi: 10.1186/1476-4598-9-99

43.
Djalila Mekahli, Geert Bultynck, Jan B. Parys, Humbert De Smedt, Ludwig Missiaen
Cold Spring Harb Perspect Biol. 2011 June; 3(6): a004317. doi: 10.1101/cshperspect.a004317

44.
Tzuu-Yuan Huang, Che-Wen Hsu, Weng-Cheng Chang, Miin-Yau Wang, June-Fu Wu, Yi-Chiang Hsu
Evid Based Complement Alternat Med. 2012; 2012: 396573. Published online 2012 February 15.doi: 10.1155/2012/396573

45.
Chureeporn Chitchumroonchokchai, Kenneth M. Riedl, Sunit Suksumrarn, Steven K. Clinton, A. Douglas Kinghorn, Mark L. Failla
J Nutr. 2012 April; 142(4): 675–680. Published online 2012 March 7. doi: 10.3945/jn.111.156992

46.
PENG ZHAO, JUN-MIN MAO, SHU-YUN ZHANG, ZE-QUAN ZHOU, YANG TAN, YU ZHANG
Oncol Lett. 2014 August; 8(2): 765–769. Published online 2014 May 19. doi: 10.3892/ol.2014.2159

No comments:

Post a Comment